Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative

Colleen Vega
Robin L. Whitney
Josef Hannah
Grant Matthew Smith
ONF 2022, 49(3), 233-241 DOI: 10.1188/22.ONF.233-241

Objectives: To evaluate the effects of virtual reality (VR) on symptom distress, such as depression, anxiety, and pain, experienced by individuals receiving allogeneic hematopoietic stem cell transplantation.

Sample & Setting: 20 participants aged 19–70 years (median age of 56.5 years) who were hospitalized in an academic setting received as many as two sessions of VR per week for two weeks.

Methods & Variables: Before and after each session, participants completed the revised Edmonton Symptom Assessment Scale (ESAS-r) to evaluate their symptoms. Paired t tests were later conducted.

Results: VR sessions showed significant improvement in 8 of the 10 symptoms addressed in ESAS-r.

Implications for Nursing: VR can improve symptoms in patients following hematopoietic stem cell transplantation in a hospital setting, provide a low-cost intervention to treat symptoms, and support future investigations exploring how VR affects prolonged hospitalizations related to distressing symptoms.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or